研究单位：[1]Department of Infectious Diseases, The Third Affliated Hospital of Sun Yat-sen University Recruiting
Guangzhou, Guangdong, China, 510630[2]Peking University[3]Huazhong University of Science and Technology[4]Nanchang University[5]Huizhou Municipal Central Hospital[6]First People's Hospital, Shunde China[7]Shenzhen Third People's Hospital[8]First People's Hospital of Foshan[9]Tang-Du Hospital[10]First Affiliated Hospital of Kunming Medical University[11]Yuebei People's Hospital
HBsAg Loss/Seroconversion is uncommon in Low replicative chronic HBV infection patients. The purpose of this study is to investigate the ability of peginterferon alpha to achieve HBsAg loss/seroconversion therapy in Low replicative chronic HBV infection patients with Low Level HBsAg.
